Post Categories
QPS CEO Dr. Benjamin Chien Featured in Innovation Delaware
January 1, 2020
The story of QPS‘s origin was recently included in the 2019/2020 issue of Innovation Delaware: Showcasing Delaware’s Innovators, which is a supplement to Delaware Business Times. In the…
QPS Physician Nutte Van Belzen Wins 2019 Young Entrepreneur Award
December 20, 2019
Entrepreneur Nutte Van Belzen of CC Diagnostics recently won the 2019 Jonge Ondernemingsprijs (Young Entrepreneur Award). Van Belzen also happens to work as a…
Small Molecule Drug Discovery Opening Doors for Chronic Disease Management
November 4, 2019
Although large molecule drug discovery has become more popular recently, small molecules have always acted as the basis for the majority of drug research…
The Importance of Animal Welfare in Preclinical In Vivo Research
October 15, 2019
Until recently, many scientists were convinced that animal welfare and high-quality animal research were not compatible. Animal welfare was considered a nuisance that should…
Working with Families in Pediatric Clinical Drug Trials
October 1, 2019
When designing pediatric clinical drug trials, it’s important to work with the entire family to ensure the experience is convenient, comfortable, and rewarding. If…
Guidance for Scheduling Clinical Trials in Children
September 24, 2019
Children are not little adults, but due to a lack of pediatric clinical trials, children are often prescribed drugs that have only been approved…
New Horizons for Patient Studies at QPS-NL
September 13, 2019
In the pharmaceutical and biotechnology industry more small and even virtual companies are established thereby changing the traditional way of working in early drug…
Solutions for Recruitment for Pediatric Clinical Trials
September 3, 2019
Did you know that only about 20 percent of drugs used today are labeled for pediatric patients? By necessity, products licensed for adults are…
Establishing Preclinical Leadership in Asia with the Addition of Mini Pig Studies
August 19, 2019
Suitable animal models are an unavoidable necessity in the testing and development of new pharmacological agents. QPS has an extensive history of conducting studies…
Establishing Leadership in Asia with SEND
August 12, 2019
As a pioneer with the Standard for Exchange Nonclinical Data (SEND) system in Asia, QPS Taiwan CTPS has taken a leadership role in implementing…
QPS Missouri Collaborates with Local Agency to Bring Birthday Celebrations to Underserved Children
August 8, 2019
Wish I May is a volunteer-run 501(c)(3) non-profit organization in the Springfield, Missouri, community striving to make a difference one child and one birthday at…
Interested in Plaque-Associated Inflammation?
July 19, 2019
Are you interested in exploring plaque-associated inflammation? QPS Neuropharmacology, a division of QPS (a leading CRO for drug development), is your partner for the visualization…
Discovery: Pupal Ants Produce Milk for Their Colonies
February 1, 2023
Pupating ants produce milk — and scientists have only just noticed. Research published in Nature in November describes researchers observing for the first time…
The Resurgence of Strep A and the Effects of the COVID-19 Pandemic
January 30, 2023
An unexpected increase in cases of streptococcal A (strep A) infection in the United Kingdom is troubling for families, healthcare practitioners, and researchers. Although…
Pigs Could Solve the Organ Transplant Crisis
January 25, 2023
2022 held a number of significant breakthroughs in researchers’ ongoing efforts to solve the organ transplant crisis. Many of those breakthroughs were in xenotransplantation,…
The Unlikely Role of Hops in the Prevention of Alzheimer’s Disease
January 23, 2023
A team of Italian scientists from the University of Milan-Bicocca have recently discovered a possible use of hops, the flowers used to enhance both…
Costly, Life-Changing Type 1 Diabetes Drug Delays Disease, Receives FDA Approval
January 16, 2023
The U.S. Food and Drug Administration has approved teplizumab-mzw (TZIELD™), a drug developed by New Jersey-based Provention Bio to delay the onset of type…
A Breakthrough in Converting Brain Waves to Speech
January 11, 2023
A new pilot study conducted by Chang Lab at UC San Francisco has demonstrated the ability to use new neurotechnology to enable paralyzed individuals…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
